BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 15674196)

  • 1. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    Surgery; 2005 Feb; 137(2):165-71. PubMed ID: 15674196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymph node dissection in surgical treatment for remnant stomach cancer.
    Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
    Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
    Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
    Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastasis and surgical management of gastric cancer invading the esophagus.
    Yonemura Y; Tsugawa K; Fonseca L; Fushida S; Matsumoto H; Ninomiya I; Sugiyama K; Fujimura T; Nishimura G; Miwa K
    Hepatogastroenterology; 1995 Feb; 42(1):37-42. PubMed ID: 7782032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach.
    Zhu GL; Sun Z; Wang ZN; Xu YY; Huang BJ; Xu Y; Zhu Z; Xu HM
    J Surg Oncol; 2012 Jun; 105(8):786-92. PubMed ID: 22105768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcome of node-positive early gastric cancer with particular reference to nodal status.
    Kikuchi S; Sato M; Katada N; Sakuramoto S; Kobayashi N; Shimao H; Sakakibara Y; Kakita A
    Anticancer Res; 2000; 20(5C):3695-700. PubMed ID: 11268441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of minimally invasive treatment for early gastric cancer.
    Hyung WJ; Cheong JH; Kim J; Chen J; Choi SH; Noh SH
    J Surg Oncol; 2004 Mar; 85(4):181-5; discussion 186. PubMed ID: 14991872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcome in early gastric cancer with lymph node metastasis.
    Hanazaki K; Wakabayashi M; Sodeyama H; Makiuchi A; Igarashi J; Yokoyama S; Sode Y; Kawamura N; Ohtsuka M; Miyazaki T
    Hepatogastroenterology; 1997; 44(15):907-11. PubMed ID: 9222713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach.
    Baba M; Hokita S; Natsugoe S; Miyazono T; Shimada M; Nakano S; Takao S; Aikou T
    Hepatogastroenterology; 2000; 47(33):893-6. PubMed ID: 10919056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications of limited surgery for gastric cancer with submucosal invasion--analysis of 715 cases with special reference to site of the tumor and level 2 lymph nodes.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(53):1727-30. PubMed ID: 14571828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
    Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
    Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical outcomes for early gastric cancer in the upper third of the stomach.
    Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    J Am Coll Surg; 2005 Jan; 200(1):15-9. PubMed ID: 15631915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of curative gastrectomy for carcinoma of the distal third of the stomach.
    Wu CW; Hsieh MC; Lo SS; Lui WY; P'eng FK
    J Am Coll Surg; 1996 Sep; 183(3):201-7. PubMed ID: 8784312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
    Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
    Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.
    Ohno S; Tomisaki S; Oiwa H; Sakaguchi Y; Ichiyoshi Y; Maehara Y; Sugimachi K
    J Am Coll Surg; 1995 May; 180(5):577-82. PubMed ID: 7749534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
    Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
    J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.